rutaevin: from root bark of Dictamnus daycarpus Turcz.
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Dictamnus | genus | A plant genus of the family RUTACEAE. Members contain eudesmane type SESQUITERPENES; COUMARINS, and obacunone (a limonoid).[MeSH] | Rutaceae | A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 441805 |
CHEMBL ID | 402437 |
CHEBI ID | 8919 |
MeSH ID | M0213922 |
Synonym |
---|
33237-37-5 |
rutaevin |
C08779 , |
chebi:8919 , |
CHEMBL402437 , |
AC1L9BP1 , |
ambap33237-37-5 |
evodinone |
Q27108190 |
(1r,2r,7s,10r,12r,13s,14r,16s,19s,20s)-19-(furan-3-yl)-12-hydroxy-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docosane-5,11,17-trione |
DTXSID40954876 |
12-(furan-3-yl)-8-hydroxy-6,6,8a,12a-tetramethyldecahydro-1h,3h-oxireno[c]pyrano[4'',3'':2',3']furo[3',4':5,6]naphtho[1,2-d]pyran-3,7,10(8h,9ah)-trionato |
E88594 |
Class | Description |
---|---|
steroid lactone | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID328119 | Neuroprotective activity against rat cortical cells at 10.0 uM assessed as glutamate-induced neurotoxicity by MTT assay | 2008 | Journal of natural products, Feb, Volume: 71, Issue:2 | Neuroprotective limonoids of root bark of Dictamnus dasycarpus. |
AID328116 | Neuroprotective activity against rat cortical cells assessed as glutamate-induced neurotoxicity by MTT assay | 2008 | Journal of natural products, Feb, Volume: 71, Issue:2 | Neuroprotective limonoids of root bark of Dictamnus dasycarpus. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |